Partner With Us

Leading drug developer organizations are repeatedly telling us that developing effective bioanalytical strategies to measure and predict immune response is a major bottleneck for them and that they have little visibility into which contract service providers and technology providers have the experience and expertize to meet their demands.

Can your products / solutions help?

At this year’s 2nd Gene Therapy Immunogenicity Summit we are set to unite 160+ clinical, immunology, pharmacology, bioanalytical and toxicology leaders from the field’s leading companies.

Snapshot Of Who's Attending in 2021:

gtxi companies (10)

Why Partner?

  • Showcase your expertize to leading organizations by securing a virtual exhibition booth
  • Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
  • Maximize the balance of 2:1 live content and targeted online networking to generate leads and build new relationships with analytical pioneers
  • Embrace the tech to meet your 2021 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively

We have a limited number of partnership opportunities available, including virtual speaking positions across our agenda. From developing robust immunogenicity assays to companion diagnostic strategies, if you provide bioanalytical services that would benefit our niche industry audience, then this meeting will provide a unique platform to showcase your solutions, generate new business leads, and source opportunities for partnerships.

Email us at sponsor@hansonwade.com for more information about the digital partnership opportunities available which will deliver on your commercial objectives in 2021 and beyond. Act now to stay ahead of the curve and seize the wealth of opportunity on offer.